Respiratory Syncytial Virus (RSV) vaccination for older people Webinar

Join us for an informative webinar exploring the new Respiratory Syncytial Virus (RSV) vaccination program for older adults and what it means for healthcare professionals working across primary care, aged care, community health, and immunisation services.

This event is delivered by Benchmarque Group with sponsorship from GSK Australia. 

RSV is a common respiratory virus that can cause serious illness in older adults, particularly those with underlying health conditions. With new vaccination recommendations and program developments emerging, it is essential that healthcare professionals remain up to date with the latest evidence, eligibility requirements, and practical implementation considerations.

This webinar will provide an overview of RSV disease burden in older Australians, current vaccine options, eligibility criteria, and key clinical considerations for supporting vaccine uptake.

Participants will also gain practical insights into communicating with patients about RSV, addressing common questions, and integrating RSV vaccination into routine preventive care. 

Program:

• Welcome and Introduction 
• Impact of RSV for Adults and Older People 
• RSV Season - when to encourage vaccination.  
• Having a conversation. 
• Funded and non-funded programs 
• Co-administration with other available vaccines 
• Question and answer session

Speakers:

• Ali Maggs: R.N. Authorised Immuniser
• Angela Newbound: R.N. Authorised Immuniser

Numbers are limited and registration is essential. This event is delivered live and is not recorded.